Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum

Molecular Microbiology

Volumn 86, Issue 1, 2012, Pages 111-128

  Cui, Long ^a   Wang, Zenglei ^a   Miao, Jun ^a   Miao, Miao ^a   Chandra, Ramesh ^a   Jiang, Hongying ^b   Su, Xin Zhuan ^b   Cui, Liwang ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; DIHYDROARTEMISININ; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MOLECULAR MARKER; MULTIDRUG RESISTANCE PROTEIN 1; SUPEROXIDE DISMUTASE; THIOREDOXIN;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE DOSAGE; IN VITRO STUDY; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE PROTEIN 1 GENE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; GENE DOSAGE; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; SELECTION, GENETIC; STRESS, PHYSIOLOGICAL;

PLASMODIUM FALCIPARUM;

EID: 84867087846     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2012.08180.x     Document Type: Article

References (90)

1. Akide-Ndunge, O.B., Tambini, E., Giribaldi, G., McMillan, P.J., Muller, S., Arese, P., and Turrini, F. (2009) Co-ordinated stage-dependent enhancement of Plasmodium falciparum antioxidant enzymes and heat shock protein expression in parasites growing in oxidatively stressed or G6PD-deficient red blood cells. Malar J 8: 113.
2. Alker, A.P., Lim, P., Sem, R., Shah, N.K., Yi, P., Bouth, D.M., etal. (2007) Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 76: 641-647.
3. Anderson, T.J., Nair, S., Qin, H., Singlam, S., Brockman, A., Paiphun, L., and Nosten, F. (2005) Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother 49: 2180-2188.
4. Becker, K., Tilley, L., Vennerstrom, J.L., Roberts, D., Rogerson, S., and Ginsburg, H. (2004) Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34: 163-189.
5. Becker, K., Koncarevic, S., and Hunt, N.H. (2005) Oxidative Stress and Antioxidant Defence in Malaria Parasites. Washington, D.C.: ASM Press.
6. Beez, D., Sanchez, C.P., Stein, W.D., and Lanzer, M. (2011) Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother 55: 50-55.
7. Bhisutthibhan, J., Pan, X.Q., Hossler, P.A., Walker, D.J., Yowell, C.A., Carlton, J., etal. (1998) The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem 273: 16192-16198.
8. Borges, S., Cravo, P., Creasey, A., Fawcett, R., Modrzynska, K., Rodrigues, L., etal. (2011) Genome-wide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine and artemisinin in P.chabaudi malaria parasites. Antimicrob Agents Chemother 55: 4858-4865.
9. Bosman, A., and Mendis, K.N. (2007) A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg 77: 193-197.
10. Cappellini, M.D., and Fiorelli, G. (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 64-74.
11. Castellini, M.A., Buguliskis, J.S., Casta, L.J., Butz, C.E., Clark, A.B., Kunkel, T.A., and Taraschi, T.F. (2011) Malaria drug resistance is associated with defective DNA mismatch repair. Mol Biochem Parasitol 177: 143-147.
12. Chandra, R., Tripathi, L.M., Saxena, J.K., and Puri, S.K. (2011) Implication of intracellular glutathione and its related enzymes on resistance of malaria parasites to the antimalarial drug arteether. Parasitol Int 60: 97-100.
13. Chavchich, M., Gerena, L., Peters, J., Chen, N., Cheng, Q., and Kyle, D.E. (2010) Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob Agents Chemother 54: 2455-2464.
14. Cheeseman, I.H., Miller, B.A., Nair, S., Nkhoma, S., Tan, A., Tan, J.C., etal. (2012) A major genome region underlying artemisinin resistance in malaria. Science 336: 79-82.
15. Cowman, A.F., Galatis, D., and Thompson, J.K. (1994) Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
16. Cui, L., and Su, X.Z. (2009) Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 7: 999-1013.
17. Cui, L., Miao, J., and Cui, L. (2007a) Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother 51: 488-494.
18. Cui, L., Miao, J., Furuya, T., Li, X., Su, X.Z., and Cui, L. (2007b) PfGCN5-mediated histone H3 acetylation plays a key role in gene expression in Plasmodium falciparum. Eukaryot Cell 6: 1219-1227.
19. Cui, L., Wang, Z., Jiang, H., Parker, D., Wang, H., Su, X.Z., and Cui, L. (2012) Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother 56: 2546-2552.
20. Dahlstrom, S., Veiga, M.I., Ferreira, P., Martensson, A., Kaneko, A., Andersson, B., etal. (2008) Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Infect Genet Evol 8: 340-345.
21. Deplaine, G., Lavazec, C., Bischoff, E., Natalang, O., Perrot, S., Guillotte-Blisnick, M., etal. (2011) Artesunate tolerance in transgenic Plasmodium falciparum parasites overexpressing a tryptophan-rich protein. Antimicrob Agents Chemother 55: 2576-2584.
22. Ding, X.C., Beck, H.P., and Raso, G. (2011) Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol 27: 73-81.
23. Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., etal. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
24. Duraisingh, M.T., and Cowman, A.F. (2005) Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181-190.
25. Duraisingh, M.T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., and Warhurst, D.C. (2000) The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108: 13-23.
26. Eckstein-Ludwig, U., Webb, R.J., Van Goethem, I.D., East, J.M., Lee, A.G., Kimura, M., etal. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961.
27. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., etal. (2000) Mutations in the P.falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
28. Gadalla, N.B., Adam, I., Elzaki, S.E., Bashir, S., Mukhtar, I., Oguike, M., etal. (2011) Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother 55: 5408-5411.
29. Ginsburg, H., and Golenser, J. (1999) Redox metabolism in glucose-6-phosphate dehydrogenase deficient erythrocytes and its relation to antimalarial chemotherapy. Parassitologia 41: 309-311.
30. Ginsburg, H., and Golenser, J. (2003) Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep 8: 276-279.
31. Ginsburg, H., Ward, S.A., and Bray, P.G. (1999) An integrated model of chloroquine action. Parasitol Today 15: 357-360.
32. Gonzales, J.M., Patel, J.J., Ponmee, N., Jiang, L., Tan, A., Maher, S.P., etal. (2008) Regulatory hotspots in the malaria parasite genome dictate transcriptional variation. PLoS Biol 6: e238.
33. Hartwig, C.L., Rosenthal, A.S., D'Angelo, J., Griffin, C.E., Posner, G.H., and Cooper, R.A. (2009) Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent. Biochem Pharmacol 77: 322-336.
34. Haynes, R.K., Chan, H.W., Lung, C.M., Ng, N.C., Wong, H.N., Shek, L.Y., etal. (2007) Artesunate and dihydroartemisinin (DHA): unusual decomposition products formed under mild conditions and comments on the fitness of DHA as an antimalarial drug. ChemMedChem 2: 1448-1463.
35. Hayward, R., Saliba, K.J., and Kirk, K. (2005) pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol 55: 1285-1295.
36. Hunt, P., Afonso, A., Creasey, A., Culleton, R., Sidhu, A.B., Logan, J., etal. (2007) Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Mol Microbiol 65: 27-40.
37. Imwong, M., Dondorp, A.M., Nosten, F., Yi, P., Mungthin, M., Hanchana, S., etal. (2010) Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother 54: 2886-2892.
38. Inselburg, J. (1985) Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. Am J Trop Med Hyg 34: 417-418.
39. Jambou, R., Legrand, E., Niang, M., Khim, N., Lim, P., Volney, B., etal. (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366: 1960-1963.
40. Klonis, N., Crespo-Ortiz, M.P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P.J., and Tilley, L. (2011) Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci USA 108: 11405-11410.
41. Krungkrai, S.R., and Yuthavong, Y. (1987) The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans R Soc Trop Med Hyg 81: 710-714.
42. Li, G.Q., Arnold, K., Guo, X.B., Jian, H.X., and Fu, L.C. (1984) Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet 2: 1360-1361.
43. Lim, P., Alker, A.P., Khim, N., Shah, N.K., Incardona, S., Doung, S., etal. (2009) Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J 8: 11.
44. Llinas, M., Bozdech, Z., Wong, E.D., Adai, A.T., and DeRisi, J.L. (2006) Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res 34: 1166-1173.
45. Martin, S.K., Oduola, A.M., and Milhous, W.K. (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
46. Meshnick, S.R. (2002) Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32: 1655-1660.
47. Miao, J., Fan, Q., Cui, L., Li, X., Wang, H., Ning, G., etal. (2010) The MYST family histone acetyltransferase regulates gene expression and cell cycle in malaria parasite Plasmodium falciparum. Mol Microbiol 78: 883-902.
48. Mockenhaupt, F.P. (1995) Mefloquine resistance in Plasmodium falciparum. Parasitol Today 11: 248-253.
49. Mok, S., Imwong, M., Mackinnon, M.J., Sim, J., Ramadoss, R., Yi, P., etal. (2011) Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12: 391.
50. Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., etal. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49: 977-989.
51. Muller, S. (2004) Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol 53: 1291-1305.
52. Natalang, O., Bischoff, E., Deplaine, G., Proux, C., Dillies, M.A., Sismeiro, O., etal. (2008) Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate. BMC Genomics 9: 388.
53. Noedl, H., Se, Y., Schaecher, K., Smith, B.L., Socheat, D., and Fukuda, M.M. (2008) Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
54. Noedl, H., Se, Y., Sriwichai, S., Schaecher, K., Teja-Isavadharm, P., Smith, B., etal. (2010) Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis 51: e82-e89.
55. Nogueira, F., Diez, A., Radfar, A., Perez-Benavente, S., do Rosario, V.E., Puyet, A., and Bautista, J.M. (2010) Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones. Acta Trop 114: 109-115.
56. Nosten, F. (2010) Waking the sleeping beauty. J Infect Dis 202: 1300-1301.
57. Oduola, A.M., Milhous, W.K., Weatherly, N.F., Bowdre, J.H., and Desjardins, R.E. (1988) Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Exp Parasitol 67: 354-360.
58. Patel, J.J., Thacker, D., Tan, J.C., Pleeter, P., Checkley, L., Gonzales, J.M., etal. (2010) Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross. Mol Microbiol 78: 770-787.
59. Pickard, A.L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., etal. (2003) Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother 47: 2418-2423.
60. del Pilar Crespo, M., Avery, T.D., Hanssen, E., Fox, E., Robinson, T.V., Valente, P., etal. (2008) Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology. Antimicrob Agents Chemother 52: 98-109.
61. Price, R.N., Cassar, C., Brockman, A., Duraisingh, M., van Vugt, M., White, N.J., etal. (1999) The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 43: 2943-2949.
62. Price, R.N., Uhlemann, A.C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., etal. (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364: 438-447.
63. Radfar, A., Diez, A., and Bautista, J.M. (2008) Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum. Free Radic Biol Med 44: 2034-2042.
64. Raj, D.K., Mu, J., Jiang, H., Kabat, J., Singh, S., Sullivan, M., etal. (2009) Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem 284: 7687-7696.
65. Rathod, P.K., McErlean, T., and Lee, P.C. (1997) Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94: 9389-9393.
66. Reed, M.B., Saliba, K.J., Caruana, S.R., Kirk, K., and Cowman, A.F. (2000) Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403: 906-909.
67. Reilly, H.B., Wang, H., Steuter, J.A., Marx, A.M., and Ferdig, M.T. (2007) Quantitative dissection of clone-specific growth rates in cultured malaria parasites. Int J Parasitol 37: 1599-1607.
68. Rodrigues, L.A., Henriques, G., Borges, S.T., Hunt, P., Sanchez, C.P., Martinelli, A., and Cravo, P. (2010) Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite. PLoS ONE 5: e11593.
69. Rosario, V. (1981) Cloning of naturally occurring mixed infections of malaria parasites. Science 212: 1037-1038.
70. Sanchez, C.P., Rotmann, A., Stein, W.D., and Lanzer, M. (2008) Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol Microbiol 70: 786-798.
71. Sanchez, C.P., Mayer, S., Nurhasanah, A., Stein, W.D., and Lanzer, M. (2011) Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum. Mol Microbiol 82: 865-878.
72. Shah, N.K., Alker, A.P., Sem, R., Susanti, A.I., Muth, S., Maguire, J.D., etal. (2008) Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia. Emerg Infect Dis 14: 1637-1640.
73. Sidhu, A.B., Valderramos, S.G., and Fidock, D.A. (2005) pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57: 913-926.
74. Sidhu, A.B., Uhlemann, A.C., Valderramos, S.G., Valderramos, J.C., Krishna, S., and Fidock, D.A. (2006) Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 194: 528-535.
75. Smilkstein, M., Sriwilaijaroen, N., Kelly, J.X., Wilairat, P., and Riscoe, M. (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48: 1803-1806.
76. Tanabe, K., Zakeri, S., Palacpac, N.M., Afsharpad, M., Randrianarivelojosia, M., Kaneko, A., etal. (2011) Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies. Antimicrob Agents Chemother 55: 94-100.
77. Teuscher, F., Gatton, M.L., Chen, N., Peters, J., Kyle, D.E., and Cheng, Q. (2010) Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis 202: 1362-1368.
78. Trotta, R.F., Brown, M.L., Terrell, J.C., and Geyer, J.A. (2004) Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum. Biochemistry 43: 4885-4891.
79. Uhlemann, A.C., Cameron, A., Eckstein-Ludwig, U., Fischbarg, J., Iserovich, P., Zuniga, F.A., etal. (2005) A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12: 628-629.
80. Valderramos, S.G., Scanfeld, D., Uhlemann, A.C., Fidock, D.A., and Krishna, S. (2010) Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance. Antimicrob Agents Chemother 54: 3842-3852.
81. WHO (2009) Development of a strategy towards elimination of Plasmodium falciparum parasites with altered responses to artemisinins. World Health Organization. pp. 1-52.
82. WHO (2010) Global report on antimalarial drug efficacy and drug resistance. p. 115.
83. WHO (2011) Global plan for artemisinin resistance containment (GPARC). p. 87.
84. Wilson, C.M., Serrano, A.E., Wasley, A., Bogenschutz, M.P., Shankar, A.H., and Wirth, D.F. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
85. Wilson, C.M., Volkman, S.K., Thaithong, S., Martin, R.K., Kyle, D.E., Milhous, W.K., and Wirth, D.F. (1993) Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57: 151-160.
86. Witkowski, B., Lelievre, J., Barragan, M.J., Laurent, V., Su, X.Z., Berry, A., and Benoit-Vical, F. (2010) Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 54: 1872-1877.
87. Wongsrichanalai, C., and Meshnick, S.R. (2008) Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis 14: 716-719.
88. Yuan, J., Johnson, R.L., Huang, R., Wichterman, J., Jiang, H., Hayton, K., etal. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol 5: 765-771.
89. Yuan, J., Cheng, K.C., Johnson, R.L., Huang, R., Pattaradilokrat, S., Liu, A., etal. (2011) Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333: 724-729.
90. Zhang, G., Guan, Y., Zheng, B., Wu, S., and Tang, L. (2008) No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China. Malar J 7: 122.